Dr. Robert B. Lajvardi, MD

Dr. Lajvardi practices at EPC Surgery Center in La Mesa, California.

Dr. Lajvardi's NPI, 1235187568, was assigned on May 5, 2006. Dr. Lajvardi graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2001. Dr. Lajvardi holds California license A89608.

Dr. Lajvardi's primary practice is EPC Surgery Center, at 7051 Alvarado Road, Suite 100, La Mesa, CA 91942. The practice phone is (619) 713-6219.

Dr. Lajvardi's primary practice is EPC Surgery Center in La Mesa, California. Dmand AI also links Dr. Lajvardi to 2 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lajvardi practices, 4 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Lajvardi's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Lajvardi's licenses on file in 2 states: California and Illinois.

Dmand AI lists acid reflux, acute skin infection, ADHD, anxiety, arthritis, asthma, atrial fibrillation and flutter and benign or precancerous skin growths among the conditions Dr. Lajvardi treats.

CMS data shows 9,188 Medicare services from Dr. Lajvardi across 15 procedure codes in 2024, for 264 Medicare patients. Medicare paid $266,583 for them. Every service was in an office.

CMS counts 264 Medicare patients who saw Dr. Lajvardi in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lajvardi's median patient age at 65, with 50% women.

In 2024, Dr. Lajvardi wrote 4,098 Medicare Part D claims for 211 patients. 85% of them were for generic drugs. CMS names the drug for 3,340 of them, across 91 drugs with 11 or more claims each, at $315,167 in total drug cost. In 2023, CMS named 3,859 claims across 104 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 23 out of 100 for Dr. Lajvardi for performance year 2024, reported individually. Dr. Lajvardi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lajvardi as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Lajvardi. The most frequent topics are Isotonic Solutions and Thoracica. Dr. Lajvardi's most frequent co-author is John B. Bitner, MD.

CMS Open Payments shows 377 general payments to Dr. Lajvardi from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,963.

Dmand AI lists 1 award for Dr. Lajvardi, most recently CMS Stage 1 2012 in 2011.

Dr. Lajvardi graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2001.

Dr. Lajvardi is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.